Qingyang Ma

683 total citations
25 papers, 362 citations indexed

About

Qingyang Ma is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Qingyang Ma has authored 25 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Qingyang Ma's work include Pharmacology and Obesity Treatment (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and RNA modifications and cancer (3 papers). Qingyang Ma is often cited by papers focused on Pharmacology and Obesity Treatment (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and RNA modifications and cancer (3 papers). Qingyang Ma collaborates with scholars based in China. Qingyang Ma's co-authors include Lei Qian, Hongwei� Jiang, Xiangyin Kong, Landian Hu, Linong Ji, Yufei Zhu, Huan Deng, Jian Ding, Meng Liu and Linghua Meng and has published in prestigious journals such as Circulation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Qingyang Ma

24 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingyang Ma China 10 144 129 81 59 53 25 362
Antoinette Bugyei‐Twum Canada 9 195 1.4× 57 0.4× 12 0.1× 69 1.2× 37 0.7× 11 416
Lingling Du China 11 122 0.8× 89 0.7× 17 0.2× 41 0.7× 75 1.4× 15 387
Hua Pang China 11 105 0.7× 74 0.6× 9 0.1× 87 1.5× 39 0.7× 57 365
C. Bombardi Italy 8 219 1.5× 45 0.3× 17 0.2× 44 0.7× 121 2.3× 8 380
Xingyu Mu China 13 326 2.3× 62 0.5× 23 0.3× 108 1.8× 158 3.0× 29 560
Maria Inês Alvelos Belgium 13 215 1.5× 109 0.8× 15 0.2× 184 3.1× 42 0.8× 20 479
Magdalena Birker Switzerland 11 133 0.9× 67 0.5× 116 1.4× 148 2.5× 12 0.2× 15 422
Xiaomei Liu China 10 146 1.0× 66 0.5× 8 0.1× 44 0.7× 60 1.1× 35 328
Sergio Alonso‐Orgaz Spain 11 138 1.0× 30 0.2× 13 0.2× 77 1.3× 67 1.3× 18 389
Wenlin Xie China 11 138 1.0× 34 0.3× 10 0.1× 50 0.8× 74 1.4× 27 365

Countries citing papers authored by Qingyang Ma

Since Specialization
Citations

This map shows the geographic impact of Qingyang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyang Ma more than expected).

Fields of papers citing papers by Qingyang Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyang Ma. The network helps show where Qingyang Ma may publish in the future.

Co-authorship network of co-authors of Qingyang Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyang Ma. A scholar is included among the top collaborators of Qingyang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyang Ma. Qingyang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Le, Hui Zhang, Jianan Li, et al.. (2025). Application of gibberellin suppresses lignin biosynthesis in the spring shoots of Camellia oleifera Abel.: An extensive study of morphologic, physiological, and molecular implications. Industrial Crops and Products. 225. 120448–120448. 1 indexed citations
2.
Ma, Qingyang, Suping Shen, Jun Lu, et al.. (2025). Full-performance coordinated design for polymer-in-salt solid electrolyte. Energy Materials. 5(3).
3.
Gao, Juanjuan, et al.. (2024). Fabrication of Hierarchical Assemblies through Temperature‐Triggered Liquid Crystallization Driven Self‐Assembly. Small Methods. 8(9). e2301525–e2301525. 3 indexed citations
4.
Wang, Han, et al.. (2024). GLT8D2 is a prognostic biomarker and regulator of immune cell infiltration in gastric cancer. Frontiers in Immunology. 15. 1370367–1370367. 2 indexed citations
5.
Zhang, Xu, Yuxiang Wang, Xi Zhang, et al.. (2023). Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors. Signal Transduction and Targeted Therapy. 8(1). 153–153. 6 indexed citations
6.
He, Jinjie, Qingyang Ma, Jicheng Yu, et al.. (2023). Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study. Expert Opinion on Investigational Drugs. 32(7). 669–675. 2 indexed citations
7.
8.
Yan, Shuling, Xia Zhao, Qingyang Ma, et al.. (2023). Pharmacokinetic/LDL‐C and exposure–response analysis of tafolecimab in Chinese hypercholesterolemia patients: Results from phase I, II, and III studies. Clinical and Translational Science. 16(12). 2791–2803. 3 indexed citations
9.
10.
Jiang, Hongwei�, Yawei Zhang, Meng Liu, et al.. (2022). A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes. Nature Communications. 13(1). 3613–3613. 36 indexed citations
11.
12.
Ma, Rongrong, Yuan Wang, Shu Zhao, et al.. (2021). Bacterial Flora in the Gill Tissues and Intestinal Tracts of Male and Female Chinese Mitten Crabs (Eriocheir sinensis) with Different Diets in a Mud Pond. Current Microbiology. 78(6). 2291–2297. 8 indexed citations
13.
Zhang, Xi, Qingyang Ma, Lan Xu, et al.. (2021). PI3Kα inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8+T cells and promoting fatty acid metabolism. Journal for ImmunoTherapy of Cancer. 9(8). e003093–e003093. 49 indexed citations
14.
Wang, Yuxiang, Xu Zhang, Qingyang Ma, et al.. (2021). Adaptive resistance to PI3Kα-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cells. Cell Death and Disease. 12(1). 85–85. 13 indexed citations
15.
Zhang, Yuchao, Qingyang Ma, Yuhang Zhang, et al.. (2020). Natural Selection on Exonic SNPs Shapes Allelic Expression Imbalance (AEI) Adaptability in Lung Cancer Progression. Frontiers in Genetics. 11. 665–665. 1 indexed citations
16.
Zhang, Hongyu, et al.. (2020). Progress and challenges of personalized neoantigens in the clinical treatment of tumors. SHILAP Revista de lepidopterología. 6. 100030–100030. 4 indexed citations
17.
Ma, Qingyang, Kaichun Wu, Hui Li, et al.. (2019). ONECUT2 overexpression promotes RAS-driven lung adenocarcinoma progression. Scientific Reports. 9(1). 20021–20021. 25 indexed citations
18.
Yin, Jie, Kai Wu, Qingyang Ma, et al.. (2019). Revisiting Non-BRCA1/2 Familial Whole Exome Sequencing Datasets Implicates NCK1 as a Cancer Gene. Frontiers in Genetics. 10. 527–527. 5 indexed citations
19.
Zhang, Liwen, Fangfang Zhou, Yufei Zhu, et al.. (2019). C/EBPα deficiency in podocytes aggravates podocyte senescence and kidney injury in aging mice. Cell Death and Disease. 10(10). 684–684. 35 indexed citations
20.
Liu, Xueling, Yichao Xu, Yuxiang Wang, et al.. (2018). Decrease in phosphorylated ERK indicates the therapeutic efficacy of a clinical PI3Kα-selective inhibitor CYH33 in breast cancer. Cancer Letters. 433. 273–282. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antoinette Bugyei‐Twum Breakdown of academic impact, for papers by Lingling Du Breakdown of academic impact, for papers by Hua Pang Breakdown of academic impact, for papers by C. Bombardi Breakdown of academic impact, for papers by Xingyu Mu Breakdown of academic impact, for papers by Maria Inês Alvelos Breakdown of academic impact, for papers by Magdalena Birker Breakdown of academic impact, for papers by Xiaomei Liu Breakdown of academic impact, for papers by Sergio Alonso‐Orgaz Breakdown of academic impact, for papers by Wenlin Xie
Rankless by CCL
2026